drugset / Trial / NCT03189615
Study Investigating the Pharmacokinetic Properties of the Drug Lu AF35700 in Subjects With Liver Impairment and in Healthy Subjects
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the impact of mild to moderate hepatic impairment on the pharmacokinetics of a single oral dose of Lu AF35700
Timeline
- Start
- 2017-05-14
- Primary completion
- 2018-02-28
- Completion
- 2018-04-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lu AF35700 | Unknown | 10 mg | Oral |
Indications
No indication recorded.